William Starling - Aug 22, 2024 Form 4 Insider Report for ASENSUS SURGICAL, INC. (ASXC)

Role
Director
Signature
/s/ Joshua Weingard as attorney-in-fact for William Starling, Jr.
Stock symbol
ASXC
Transactions as of
Aug 22, 2024
Transactions value $
$0
Form type
4
Date filed
8/22/2024, 09:06 AM
Previous filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASXC Common Stock Disposed to Issuer -13.8K -100% 0 Aug 22, 2024 Direct F1
transaction ASXC Common Stock Disposed to Issuer -39.1K -100% 0 Aug 22, 2024 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

William Starling is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reported securities were disposed of pursuant to the terms of an Agreement and Plan of Merger (the "Merger Agreement")dated as of June 6, 2024, by and among Asensus Surgical, Inc., a Delaware corporation ("Asensus"), KARL STORZ Endoscopy-America, Inc., a California corporation ("Parent"), and Karl Storz California Inc., a California corporation ("Merger Sub"), pursuant to which Merger Sub merged with and into Asensus with Asensus as the surviving corporation of the merger (the "Merger"). Upon the effective time of the Merger, the reporting person received $0.35 in cash, without interest and less applicable withholding taxes for each share of common stock.